Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Achieving glycaemic control an...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Achieving glycaemic control and weight loss with incretin-based therapies: a comparison of liraglutide, exenatide, and sitagliptin
Bibliographic Details
Main Authors:
Zinman, B
,
Gough, S
,
Pratley, R
,
Brett, J
,
Lund, N
,
Buse, J
Format:
Conference item
Published:
2011
Holdings
Description
Similar Items
Staff View
Similar Items
Liraglutide achieved greater weight reduction and improved glycaemic control compared with sitagliptin following one-year treatment when both are used in combination with metformin
by: Matthews, DR, et al.
Published: (2011)
Liraglutide More Effectively Achieves a Composite Endpoint for A1C, SBP and Weight Change Than Other Diabetes Therapies
by: Zinman, B, et al.
Published: (2009)
Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes
by: Catherine A Schnabel, et al.
Published: (2006-03-01)
ACUTE PANCREATITIS ASSOCIATED WITH EXENATIDE AND LIRAGLUTIDE: A META-ANALYSIS
by: Carlos Alves, et al.
Published: (2012-09-01)
Acute Pancreatitis Associated with Exenatide and Liraglutide: a Meta-Analysis
by: Carlos Alves, et al.
Published: (2012-07-01)